CV Sciences, Inc. (CVSI)

Market Cap	5.53M
Revenue (ttm)	15.62M
Net Income (ttm)	-2.54M
Shares Out	184.26M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	402,328
Average Volume	380,294
Open	0.0334
Previous Close	0.0300
Day's Range	0.0304 - 0.0334
52-Week Range	0.0300 - 0.1000
Beta	0.66
RSI	38.01
Earnings Date	Mar 28, 2025

About CV Sciences

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 43
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVSI